Symbolbild · KI-generiert
Planet 13 Holdings Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Each Warrant shall entitle the holder thereof to purchase one common share of the company upon payment of an exercise price of US$0.77, subject to the terms of the warrant agreement governing the warrants (the “Warrant Agreement”). See the Warrant Agreement for full details and conditions.
Company description as published by the issuer via Canadian Securities Exchange.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Planet 13 Holdings Inc. | PLTH | CSE | 38 Mio. USD |
| Arch Biopartners Inc. | ARCH | TSXV | 39 Mio. USD |
| BioMark Diagnostics Inc. | BUX | CSE | 43 Mio. USD |
| LSL Pharma Group Inc. | LSL | TSXV | 34 Mio. USD |
| BetterLife Pharma Inc. | BETR | CSE | 33 Mio. USD |
| Ocumetics Technology Corp. | OTC | TSXV | 43 Mio. USD |
| Covalon Technologies Ltd. | COV | TSXV | 44 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.